Promoting and facilitating strategies to improve cardiovascular health worldwide

Meeting Highlights

From the 26th Annual Scientific Meeting of the ISCP – Singapore

 

 

Tratamiento con ACOD en pacientes con FA post-ICP

ISCP On-Demand Webinar

 

 

ISCP Webinar: Cardiovascular Risk Management of Diabetes and SGLT2 Inhibitors

 

newsfeed

Morning vs. afternoon AVR may not impact 2-year mortality, rehospitalization

Posted on January 23, 2022

Procedural time of day appeared to have no influence on 2-year outcomes among intermediate-to-high-risk patients who underwent elective surgical or transcatheter aortic... more

Mortality rates decline for patients with non-STEMI, remain stable in STEMI

Posted on January 22, 2022

Risk factors for patients with acute MI have changed modestly as treatment has improved, with mortality rates significantly declining for patients with... more

Q&A: What are physicians’ legal obligations under the Americans with Disabilities Act?

Posted on January 21, 2022

The results of a new survey suggest that many physicians do not completely understand what the Americans with Disabilities Act means for... more

Optimal subarachnoid hemorrhage treatment occurs within 12.5 hours of symptom onset

Posted on January 21, 2022

Surgical treatment at approximately 12.5 hours after aneurysmal subarachnoid hemorrhage correlated with improved outcomes, according to results of a cohort study published... more

ISCP book series

Current Cardiovascular Therapy
Kaski, Juan Carlos.

Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...

  • Antiplatelet and Anticoagulation Therapy

    A. Ferro, D.A. Garcia (Eds.)

  • Pharmacological Treatment of Acute Coronary Syndromes

    Avanzas, Pablo; Clemmensen, Peter(Eds.)

  • Atrial Fibrillation Therapy

    Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)

board of directors

Providing a leadership and advocacy role amongst members of their national societies.

 

  •   Thomas Kahan

    President

    Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine (more…) more

  •   Pablo Avanzas

    Secretary

    Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of (more…) more

  •   Sang Hong Baek

    VP/President Elect

    Professor Sang Hong Baek is Director of Heart Failure and Transplantation Programme and Preventive Cardiology at Seoul St. Mary's (more…) more

  •   Georg Noll

    Treasurer

      Georg Noll is a specialist in General Internal Medicine and Cardiology at Heart Clinic Zurich. He was Associate Professor of Cardiology (more…) more